Ep 25 - John Robson - True Venture Capital vs. Vulture Capital

Today’s guest is John Robson (JR), General Manager at Bridgewest Ventures NZ, and Managing Director of BioOra, a company that is automating the manufacture of CAR T-cells.

This episode is brought to you by SAPRO Consulting: https://www.saproconsulting.com.au/

The development of new technologies, whether it be medical or otherwise, requires a lot of resources. One of those resources is capital - financial capital. Financial capital for new ventures can come in many forms, including loans from Mom & Pop or the bank, angel investment, grants, or private capital.

One of the forms of private capital is venture capital, or VC. VC is characterised by investment in young companies with growth potential. But it's not just about the money. As JR puts it, no founder has every said they were successful because they had an endless supply of money...

In this episode, and I discuss: The idiosyncrasies of the New Zealand start-up ecosystem Venture Capital's role to play in the ecosystem Bridgwest's portfolio of companies working in the CAR space ....and much much more.

You can find out more about John Robson and Bridgewest Ventures here: LinkedIn - John Robson (JR) LinkedIn - Bridgewest Ventures https://bridgewest.ventures/ https://bioora.com/

Timestamps: 00:00 Teaser 00:30 Introduction 02:20 True Venture Capital vs. Vulture Capital 05:00 Early Stage / Deep Tech Investment 09:20 Improving the status quo - Infrastructure, Human Capital, Regulation 16:00 Money follows success 20:33 Shaping the world around you 23:15 Doing more with less 25:20 It's not just about the money 26:10 Celebrating, and advertising, our successes 29:45 Where does the money come from - Bridgewest edition 34:30 Industry average is one in ten companies 36:20 Early VC - TechTransfer Office involvement 40:00 Founder Equity - Bespoke arrangements 44:00 Bridgewest's CAR portfolio companies 53:15 Advice for Biotech entrepreneurs

To get in touch head to: https://www.instagram.com/_good_clinical/

Vulture Capital vs. True Venture Capital | John Robson | Ep 25 #goodclinical #goodclinicalpodcast #goodclinicalexplains #goodclinicalevents #goodclinicalnetwork #innovation #podcast #newzealand #commercialization #venturecapital #vc #clinicalresearchassociate #technologytransfer #biotech #science #choices #country #entrepreneur #products #clinicalresearch #biotech #clinicalpractice #chatgcp #healthcare #clinicaltrials #medicine #humanhealth